Vimarsana
Biggest News Aggregation in the World

Page 25 - Olid News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Olid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Olid Today - Breaking & Trending Today

Takeda Pharmaceutical's Fiscal Year Net Profit Rose Sharply - Vimarsana News

Takeda Pharmaceutical's Fiscal Year Net Profit Rose Sharply

By Ronnie Harui Takeda Pharmaceutical's fiscal-year net profit rose sharply, mainly thanks to solid growth in its key business areas. The Japanese drug maker said in a filing with the... | May 11, 2023

Deutsche Telekom : For once Germany is driving EBITDA growth - Vimarsana News

Deutsche Telekom : For once Germany is driving EBITDA growth

EARNINGS/SALES RELEASESA fairly solid set of Q1 numbers for DT in Europe . We remain impressed, in particular, by Germany which posted 3% revenue growth and, above all, 4% EBITDAaL growth due to a... | May 11, 2023

VERBIO Vereinigte BioEnergie AG: Recovery in Bioethanol segment leads to solid Q3 2022/23 earnings - Vimarsana News

VERBIO Vereinigte BioEnergie AG: Recovery in Bioethanol segment leads to solid Q3 2022/23 earnings

EQS-News: VERBIO Vereinigte BioEnergie AG / Key word: 9 Month figures VERBIO Vereinigte BioEnergie AG: Recovery in Bioethanol segment leads to solid Q3 2022/23 earnings 11.05.2023... | May 11, 2023

Telefonica : Cash flow should improve in 2023 despite the inflationary pressures on EBITDA - Vimarsana News

Telefonica : Cash flow should improve in 2023 despite the inflationary pressures on EBITDA

EARNINGS/SALES RELEASESTelefonica released a mixed Q1 with a solid 4.9% yoy organic revenue growth but an EBITDA up by only 1.1% due to higher energy costs and personnel expenses. Capex was however... | May 11, 2023

Recordati ups guidance on strong growth in specialty, primary care markets - Vimarsana News

Recordati ups guidance on strong growth in specialty, primary care markets

Italian drug maker Recordati hiked its 2023 guidance on Thursday, as it posted first-quarter results showing solid growth for its specialty and primary care segments.... | May 11, 2023